Albany International Reports First-Quarter Results
First-quarter Highlights
-
Net sales were
$230.0 million , an increase of 15.4% compared to 2017 (see Table 2). Excluding the impact of the adoption of the new revenue recognition standard (ASC 606) and currency translation effects, Net sales increased 6.6% (see Table 3). -
Net income attributable to the Company was
$10.2 million ($0.32 per share), compared to$10.8 million ($0.34 per share) in Q1 2017. Net income attributable to the Company was increased by$1.2 million ($0.04 per share) as a result of adopting ASC 606. -
Net income attributable to the Company, excluding adjustments (a
non-GAAP measure), was
$0.54 per share, compared to$0.46 per share in Q1 2017 (see Table 14). -
Adjusted EBITDA (a non-GAAP measure) was
$50.9 million , compared to$43.5 million in Q1 2017 (see Tables 10 and 11).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180507006063/en/
Q1 2018 Income before income taxes was
Effective
Table 1 |
||||||||||||||||||
Increase/(decrease) attributable to application of ASC
(in thousands) |
Machine |
Albany |
Income tax |
Total |
||||||||||||||
Net sales | $4,211 | $4,223 | $- | $8,434 | ||||||||||||||
Gross profit | 1,039 | 869 | - | 1,908 | ||||||||||||||
Selling, technical, general and research expenses | 60 | - | - | 60 | ||||||||||||||
Operating income and Income before income taxes | 979 | 869 | - | 1,848 | ||||||||||||||
Income taxes | - | - | 601 | 601 | ||||||||||||||
Net income | 979 | 869 | (601 | ) | 1,247 | |||||||||||||
Net income attributable to the noncontrolling interest | - | - | 57 | 57 | ||||||||||||||
Net income attributable to the Company | $979 | $869 | $(658 | ) | $1,190 | |||||||||||||
Table 2 summarizes Net sales and the effect of changes in currency translation rates:
Table 2 |
|||||||||||||||||
(in thousands, excluding percentages) |
Net Sales |
Percent |
Impact of |
Percent |
|||||||||||||
2018 |
2017 |
||||||||||||||||
Machine Clothing (MC) | $148,151 | $142,827 | 3.7 | % | $6,760 | -1.0 | % | ||||||||||
Albany Engineered Composites (AEC) | 81,830 | 56,450 | 45.0 | 2,311 | 40.9 | ||||||||||||
Total | $229,981 | $199,277 | 15.4 | % | $9,071 | 10.9 | % | ||||||||||
Table 3 summarizes Q1 Net sales excluding the impact of ASC 606 and currency translation effects:
Table 3 |
||||||||||||||||
(in thousands, excluding percentages) |
Q1 2018 |
Increase due |
Increase due |
Q1 2018 |
Percent |
|||||||||||
Machine Clothing | $148,151 | $4,211 | $6,760 | $137,180 | -4.0 | % | ||||||||||
Albany Engineered Composites | 81,830 | 4,223 | 2,311 | 75,296 | 33.4 | |||||||||||
Total | $229,981 | $8,434 | $9,071 | $212,476 | 6.6 | % | ||||||||||
In Machine Clothing, when excluding the impact of ASC 606 and currency
translation effects, Net sales declined 4%, principally due to
continuing declines in publication grade sales and lower sales in tissue
and packaging, primarily in
Table 4 summarizes Gross profit by segment:
Table 4 |
||||||||||||||||
|
Three Months ended |
Three Months ended |
||||||||||||||
(in thousands, excluding percentages) |
Gross profit |
Percent of sales | Gross profit | Percent of sales | ||||||||||||
Machine Clothing | $70,181 | 47.4 | % | $69,218 | 48.5 | % | ||||||||||
Albany Engineered Composites | 11,524 | 14.1 | 6,833 | 12.1 | ||||||||||||
Corporate expenses | (54 | ) | - | (23 | ) | - | ||||||||||
Total | $81,651 | 35.5 | % | $76,028 | 38.2 | % | ||||||||||
First-quarter MC Gross profit as a percentage of sales decreased compared to Q1 2017, but was essentially flat compared to the full-year margin in 2017 and rebounded from 45.0% in Q4 2017, due to increased capacity utilization. The increase in AEC Gross profit as a percentage of sales was driven by higher sales and improved labor productivity.
Table 5 summarizes selling, technical, general and research (STG&R) expenses by segment:
Table 5 |
||||||||||||||
(in thousands, excluding percentages) |
Three Months ended |
Three Months ended |
||||||||||||
STG&R Expense |
Percent of sales |
STG&R Expense |
Percent of sales |
|||||||||||
Machine Clothing | $31,060 | 21.0 | % | $30,845 | 21.6 | % | ||||||||
Albany Engineered Composites | 9,028 | 11.0 | 9,376 | 16.6 | ||||||||||
Corporate expenses | 12,159 | - | 10,448 | - | ||||||||||
Total | $52,247 | 22.7 | % | $50,669 | 25.4 | % | ||||||||
Losses from the revaluation of nonfunctional-currency assets and
liabilities increased total first-quarter STG&R expenses by
Table 6 summarizes first-quarter expenses associated with internally funded research and development by segment:
Table 6 |
||||||
Research and development expenses |
||||||
Three Months ended |
||||||
March 31, |
||||||
(in thousands) | 2018 | 2017 | ||||
Machine Clothing | $4,418 | $4,519 | ||||
Albany Engineered Composites | 3,148 | 3,076 | ||||
Total | $7,566 | $7,595 | ||||
Table 7 summarizes first-quarter operating income by segment:
Table 7 |
||||||
Operating Income/(loss) | ||||||
Three Months ended | ||||||
|
March 31, | |||||
(in thousands) |
2018 |
2017 |
||||
Machine Clothing | $30,769 | $38,263 | ||||
Albany Engineered Composites | 2,275 | (5,114) | ||||
Corporate expenses | (12,213) | (10,471) | ||||
Total | $20,831 | $22,678 | ||||
Table 8 presents the effect on Operating income from restructuring and currency revaluation:
Table 8 |
||||||||||||
(in thousands) |
Expenses/(gain) in Q1 2018 |
Expenses/(gain) in Q1 2017 |
||||||||||
Restructuring |
Revaluation |
Restructuring |
Revaluation |
|||||||||
Machine Clothing | $8,352 | $1,517 | $110 | $1,663 | ||||||||
Albany Engineered Composites | 221 | 186 | 2,571 | 98 | ||||||||
Corporate expenses | - | (3) | - | 1 | ||||||||
Total | $8,573 | $1,700 | $2,681 | $1,762 | ||||||||
In the first quarter of 2018, the Company’s proposal to close its
Machine Clothing production facility in Sélestat,
Q1 2018 Other income/expense, net, was expense of
Table 9 summarizes currency revaluation effects on certain financial metrics:
Table 9 |
||||||
(in thousands) |
Income/(loss) attributable to currency revaluation |
|||||
2018 |
2017 |
|||||
Operating income | $(1,700) | $(1,762) | ||||
Other income/(expense), net | (690) | (101) | ||||
Total | $(2,390) | $(1,863) | ||||
The Company’s income tax rate based on income from continuing operations
was 32.5% for Q1 2018, compared to 32.6% for Q1 2017. Discrete tax items
decreased income tax expense by
Tables 10 and 11 provide a reconciliation of Operating income and Net income to EBITDA and Adjusted EBITDA:
Table 10 |
||||||||||||
Three Months ended March 31, 2018 |
Machine |
Albany |
Corporate |
Total |
||||||||
Operating income/(loss) (GAAP) | $30,769 | $2,275 | $(12,213) | $20,831 | ||||||||
Interest, taxes, other income/expense | - | - | (10,349) | (10,349) | ||||||||
Net income (GAAP) | 30,769 | 2,275 | (22,562) | 10,482 | ||||||||
Interest expense, net | - | - | 4,288 | 4,288 | ||||||||
Income tax expense | - | - | 4,609 | 4,609 | ||||||||
Depreciation and amortization | 8,362 | 11,156 | 1,430 | 20,948 | ||||||||
EBITDA (non-GAAP) | 39,131 | 13,431 | (12,235) | 40,327 | ||||||||
Restructuring expenses, net | 8,352 | 221 | - | 8,573 | ||||||||
Foreign currency revaluation losses | 1,517 | 186 | 687 | 2,390 | ||||||||
Pretax (income) attributable to non-controlling interest in ASC | - | (343) | - | (343) | ||||||||
Adjusted EBITDA (non-GAAP) | $49,000 | $13,495 | $(11,548) | $50,947 | ||||||||
Table 11 |
||||||||||||
Three Months ended March 31, 2017 |
Machine |
Albany |
Corporate |
Total |
||||||||
Operating income/(loss) (GAAP) | $38,263 | $(5,114) | $(10,471) | $22,678 | ||||||||
Interest, taxes, other income/expense | - | - | (11,704) | (11,704) | ||||||||
Net income (GAAP) | 38,263 | (5,114) | (22,175) | 10,974 | ||||||||
Interest expense, net | - | - | 4,328 | 4,328 | ||||||||
Income tax expense | - | - | 6,550 | 6,550 | ||||||||
Depreciation and amortization | 8,287 | 7,804 | 1,202 | 17,293 | ||||||||
EBITDA (non-GAAP) | 46,550 | 2,690 | (10,095) | 39,145 | ||||||||
Restructuring expenses, net | 110 | 2,571 | - | 2,681 | ||||||||
Foreign currency revaluation losses | 1,663 | 98 | 102 | 1,863 | ||||||||
Pretax (income) attributable to non-controlling interest in ASC | - | (171) | - | (171) | ||||||||
Adjusted EBITDA (non-GAAP) | $48,323 | $5,188 | $(9,993) | $43,518 | ||||||||
Payments for capital expenditures were
CFO Comments
CFO and Treasurer
“First-quarter cash flow was negatively impacted by incentive
compensation payments and high first-quarter tax payments. Additionally,
cash utilized for other working capital increased during the quarter,
most notably accounts receivable for AEC. Overall, total debt increased
about
“Capital expenditures during the quarter were about
“The Company’s income tax rate based on income from continuing
operations was 32.5% in Q1 compared to 32.6% in 2017. The tax rate for
Q1 2018 is somewhat higher than expected as additional elements of the
new U.S. tax legislation are incorporated into the rate calculation.
Cash paid for income taxes was about
CEO Comments
CEO
“MC sales in the first quarter, excluding the impact of ASC 606 and
currency translation effects, declined 4% compared to last year,
principally due to continuing declines in publication grade sales and
lower sales in tissue and packaging, primarily in
“Despite continuing inflationary pressure on our operational costs, MC gross margin was strong during the quarter at 47.4%. As expected, gross margin bounced back from the fourth-quarter gross margin of 45.0%, primarily due to improved capacity utilization. Operating income was down compared to last year due to the French restructuring charges. Adjusted EBITDA, however, was strong and stable compared to Q1 2017.
“The MC outlook for the rest of 2018 looks promising. The business
appears to be stable going into the second quarter and we currently
anticipate relatively consistent gross margins throughout the rest of
the year. Assuming no significant changes in global economic conditions,
we are on track for full-year Adjusted EBITDA in the upper half of our
expected range of
“AEC had a strong quarter with growth in Net sales, Operating income and Adjusted EBITDA compared to Q1 2017. AEC had strong year-over-year revenue growth with Net sales, excluding the impact of ASC 606 and currency translation effects, increasing 33%, consistent with our outlook communicated in the last earnings release.
“The increase in sales was primarily driven by several high-growth
aerospace platforms, such as the LEAP program as well as key
next-generation commercial and defense airframe programs. Sales of fan
cases, fan blades and spacers for LEAP engines, which represented about
49% of AEC Q1 2018 sales, grew 60% compared to Q1 2017, reflecting the
steep, unprecedented ramp up of this jet engine program. Higher sales of
“AEC Operating income improved to
“New business opportunities include further share gains on existing
platforms leveraging existing and derivative technologies, in addition
to content on potential future commercial and defense programs through
the use of new technologies. Our R&D new product development activities
during the quarter progressed in each of these areas, while R&D process
improvement projects also supported existing growth programs. Based on
this progress, we continue to project that the combination of execution
on our existing contracts along with anticipated new contract wins,
provides the potential for AEC to reach annual sales of
“AEC’s outlook for the full year 2018 is unchanged from the expectations we stated in the last earnings release: Net sales, year-over-year, should increase 20% to 30% while Adjusted EBITDA as a percentage of Net sales should show incremental improvement in 2018. Beyond 2018, we remain on track toward our goal of 18% to 20% Adjusted EBITDA as a percentage of sales in 2020.
“So in summary, this was a good quarter for the Company, with continued strong and stable performance in MC and robust sales growth with increasing profitability in AEC. Our outlook for both businesses in 2018 is unchanged, as we continue to expect strong performance by both businesses throughout the balance of the year.”
About
This release contains certain non-GAAP metrics, including: net sales, and percent change in net sales, excluding the impact of ASC 606 and/or currency translation effects (for each segment and the Company as a whole); EBITDA and Adjusted EBITDA (for each segment and the Company as a whole, represented in dollars or as a percentage of net sales); net debt; and net income per share attributable to the Company, excluding adjustments. Such items are provided because management believes that, when reconciled from the GAAP items to which they relate, they provide additional useful information to investors regarding the Company’s operational performance.
Presenting sales and increases or decreases in sales, after currency effects and/or ASC 606 impact are excluded, can give management and investors insight into underlying sales trends. EBITDA, or net income with interest, taxes, depreciation, and amortization added back, is a common indicator of financial performance used, among other things, to analyze and compare core profitability between companies and industries because it eliminates effects due to differences in financing, asset bases and taxes. An understanding of the impact in a particular quarter of specific restructuring costs, currency revaluation, inventory write-offs associated with discontinued businesses, or other gains and losses, on net income (absolute as well as on a per-share basis), operating income or EBITDA can give management and investors additional insight into core financial performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect. Restructuring expenses in the MC segment, while frequent in recent years, are reflective of significant reductions in manufacturing capacity and associated headcount in response to shifting markets, and not of the profitability of the business going forward as restructured. Net debt is, in the opinion of the Company, helpful to investors wishing to understand what the Company’s debt position would be if all available cash were applied to pay down indebtedness. EBITDA, Adjusted EBITDA and net income per share attributable to the Company, excluding adjustments, are performance measures that relate to the Company’s continuing operations.
Net sales, or percent changes in net sales, excluding currency rate effects, are calculated by converting amounts reported in local currencies into U.S. dollars at the exchange rate of a prior period. The impact of ASC 606 is determined by calculating what GAAP net sales would have been under the prior ASC 605 standard, and comparing that amount to the amount reported under the new ASC 606 standard. These amounts are then compared to the U.S. dollar amount as reported in the current period. The Company calculates EBITDA by removing the following from Net income: Interest expense net, Income tax expense, Depreciation and amortization. Adjusted EBITDA is calculated by: adding to EBITDA costs associated with restructuring, and inventory write-offs associated with discontinued businesses; adding (or subtracting) revaluation losses (or gains); subtracting (or adding) gains (or losses) from the sale of buildings or investments; subtracting insurance recovery gains in excess of previously recorded losses; and subtracting (or adding) Income (or loss) attributable to the non-controlling interest in Albany Safran Composites (ASC). Adjusted EBITDA may also be presented as a percentage of net sales by dividing it by net sales. Net income per share attributable to the Company, excluding adjustments, is calculated by adding to (or subtracting from) net income attributable to the Company per share, on an after-tax basis: restructuring charges; inventory write-offs associated with discontinued businesses; discrete tax charges (or gains) and the effect of changes in the income tax rate; foreign currency revaluation losses (or gains); acquisition expenses; and losses (or gains) from the sale of investments.
EBITDA, Adjusted EBITDA, and net income per share attributable to the Company, excluding adjustments, as defined by the Company, may not be similar to similarly named measures of other companies. Such measures are not considered measurements under GAAP, and should be considered in addition to, but not as substitutes for, the information contained in the Company’s statements of income.
The Company discloses certain income and expense items on a per-share basis. The Company believes that such disclosures provide important insight into underlying quarterly earnings and are financial performance metrics commonly used by investors. The Company calculates the quarterly per-share amount for items included in continuing operations by using the income tax rate based on income from continuing operations and the weighted-average number of shares outstanding for each period. Year-to-date earnings per-share effects are determined by adding the amounts calculated at each reporting period.
Tables 12 and 13 contain Q1 per share effects of certain income and expense items:
Table 12 |
||||||||||||
Three Months ended March 31, 2018 |
Pretax |
Tax Effect |
After-tax Effect |
Per Share |
||||||||
Restructuring expenses, net | $8,573 | $2,786 | $5,787 | $0.18 | ||||||||
Foreign currency revaluation losses | 2,390 | 777 | 1,613 | 0.05 | ||||||||
Net discrete income tax benefit | - | 290 | 290 | 0.01 | ||||||||
Favorable effect of applying ASC 606 | 1,848 | 658 * | 1,190 | 0.04 | ||||||||
* includes tax and noncontrolling interest effects |
Table 13 |
||||||||||||
Three Months ended March 31, 2017 |
Pretax |
Tax Effect |
After-tax |
Per Share Effect |
||||||||
Restructuring expenses, net | $2,681 | $979 | $1,702 | $0.05 | ||||||||
Foreign currency revaluation losses | 1,863 | 680 | 1,183 | 0.04 | ||||||||
Net discrete income tax charge | - | 831 | 831 | 0.03 | ||||||||
Table 14 contains the calculation of Net income per share attributable to the Company, excluding adjustments:
Table 14 |
|||||||
Three Months ended |
|||||||
March 31, | |||||||
Per share amounts (Basic) | 2018 | 2017 | |||||
Net income attributable to the Company, reported (GAAP) | $0.32 | $0.34 | |||||
Adjustments: | |||||||
Restructuring expenses, net | 0.18 | 0.05 | |||||
Discrete tax adjustments | (0.01 | ) | 0.03 | ||||
Foreign currency revaluation losses | 0.05 | 0.04 | |||||
Net income attributable to the Company, excluding adjustments (non-GAAP) | $0.54 | $0.46 | |||||
Table 15 contains the calculation AEC Adjusted EBITDA as a percentage of sales:
Table 15 |
||||||||||||||||||
|
Adjusted EBITDA as a percentage of net sales |
|||||||||||||||||
|
||||||||||||||||||
(in thousands, except percentages) |
March 31, |
December 31, |
September 30, |
June 30, |
March 31, |
December 31, |
||||||||||||
2018 |
2017 | 2017 | 2017 | 2017 | 2016 | |||||||||||||
Adjusted EBITDA (non-GAAP) |
$13,495 |
$10,794 |
$8,125 |
$(8,586)* |
$5,188 |
$5,530 |
||||||||||||
Net sales (GAAP) | $81,830 | $76,465 | $71,447 | $68,999 | $56,450 | $68,302 | ||||||||||||
Adjusted EBITDA as a percentage of net sales | 16.5% | 14.1% | 11.4% | (12.4)% | 9.2% | 8.1% | ||||||||||||
* Includes charge of $15.8 million in Q2 2017 for revisions in estimated profitability of two AEC contracts. |
||||||||||||||||||
Table 16 contains the calculation of net debt:
Table 16 |
||||||||||||||||||
(in thousands) |
March 31, |
December |
September 30, |
June 30, |
March 31, |
December 31, |
||||||||||||
Notes and loans payable | $226 | $262 | $186 | $249 | $274 | $312 | ||||||||||||
Current maturities of long-term debt | 1,821 | 1,799 | 51,765 | 51,732 | 51,699 | 51,666 | ||||||||||||
Long-term debt | 518,656 | 514,120 | 453,578 | 444,030 | 428,477 | 432,918 | ||||||||||||
Total debt | 520,703 | 516,181 | 505,529 | 496,011 | 480,450 | 484,896 | ||||||||||||
Cash and cash equivalents | 151,426 | 183,727 | 153,465 | 138,792 | 143,333 | 181,742 | ||||||||||||
Net debt | $369,277 | $332,454 | $352,064 | $357,219 | $337,117 | $303,154 | ||||||||||||
Table 17 contains the reconciliation of MC 2018 projected Adjusted EBITDA to MC 2018 projected net income:
Table 17 |
||||||||||||
Machine Clothing Full-Year 2018 Outlook
|
Actual, three |
Results for |
Results for |
Estimated |
||||||||
Net income (non-GAAP) | $31 | $107 |
$122 |
$138 - $153 |
||||||||
Depreciation and amortization | 8 |
24 |
24 |
32 |
||||||||
EBITDA (non-GAAP) | $39 | $131 | $146 | $170 - $185 | ||||||||
Restructuring expenses | 8 | * | * | * | ||||||||
Foreign currency revaluation losses | 2 | * | * | * | ||||||||
Adjusted EBITDA (non-GAAP) | $49 | $131 | $146 | $180 - $195 | ||||||||
* Due to the uncertainty of these items, management is currently unable to project restructuring expenses and foreign currency revaluation gains/losses for 2018. |
||||||||||||
This press release may contain statements, estimates, or projections that constitute “forward-looking statements” as defined under U.S. federal securities laws. Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,” “will,” “should,” “look for,” and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties (including, without limitation, those set forth in the Company’s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q) that could cause actual results to differ materially from the Company’s historical experience and our present expectations or projections.
Forward-looking statements in this release or in the webcast include,
without limitation, statements about macroeconomic and paper-industry
trends and conditions during 2018 and in future years; expectations in
2018 and in future periods of sales, EBITDA, Adjusted EBITDA (both in
dollars and as a percentage of net sales), income, gross profit, gross
margin, cash flows and other financial items in each of the Company’s
businesses, and for the Company as a whole; the timing and impact of
production and development programs in the Company’s AEC business
segment and the sales growth potential of key AEC programs, as well as
AEC as a whole; the amount and timing of capital expenditures, future
tax rates and cash paid for taxes, depreciation and amortization; future
debt and net debt levels and debt covenant ratios; the impact of the new
revenue recognition standard on financial results for each business
segment and for the Company as a whole; the impact of the U.S. tax
legislation passed in Q4 2017; the timing and impact of the
restructuring in
Statements expressing management’s assessments of the growth potential of its businesses, or referring to earlier assessments of such potential, are not intended as forecasts of actual future growth, and should not be relied on as such. While management believes such assessments to have a reasonable basis, such assessments are, by their nature, inherently uncertain. This release and earlier releases set forth a number of assumptions regarding these assessments, including historical results, independent forecasts regarding the markets in which these businesses operate, and the timing and magnitude of orders for our customers’ products. Historical growth rates are no guarantee of future growth, and such independent forecasts and assumptions could prove materially incorrect in some cases.
ALBANY INTERNATIONAL CORP. | ||||||
CONSOLIDATED STATEMENTS OF INCOME | ||||||
(in thousands, except per share amounts) | ||||||
(unaudited) | ||||||
Three Months Ended | ||||||
March 31, | ||||||
2018 | 2017 | |||||
Net sales | $229,981 | $199,277 | ||||
Cost of goods sold | 148,330 | 123,249 | ||||
Gross profit | 81,651 | 76,028 | ||||
Selling, general, and administrative expenses | 41,930 | 40,407 | ||||
Technical and research expenses | 10,317 | 10,262 | ||||
Restructuring expenses, net | 8,573 | 2,681 | ||||
Operating income | 20,831 | 22,678 | ||||
Interest expense, net | 4,288 | 4,328 | ||||
Other expense, net | 1,452 | 826 | ||||
Income before income taxes | 15,091 | 17,524 | ||||
Income tax expense | 4,609 | 6,550 | ||||
Net income | 10,482 | 10,974 | ||||
Net income attributable to the noncontrolling interest | 237 | 135 | ||||
Net income attributable to the Company | $ 10,245 | $ 10,839 | ||||
Earnings per share attributable to Company shareholders - Basic | $ 0.32 | $ 0.34 | ||||
Earnings per share attributable to Company shareholders - Diluted | $ 0.32 | $ 0.34 | ||||
Shares of the Company used in computing earnings per share: | ||||||
Basic | 32,220 | 32,128 | ||||
Diluted | 32,236 | 32,164 | ||||
Dividends declared per share, Class A and Class B | $ 0.17 | $ 0.17 |
ALBANY INTERNATIONAL CORP. | ||||||||
CONSOLIDATED BALANCE SHEETS | ||||||||
(in thousands, except share data) | ||||||||
(unaudited) | ||||||||
March 31, | December 31, | |||||||
2018 | 2017 | |||||||
ASSETS | ||||||||
Cash and cash equivalents | $151,426 | $183,727 | ||||||
Accounts receivable, net | 248,538 | 202,675 | ||||||
Contract assets | 42,895 | - | ||||||
Inventories | 100,034 | 136,519 | ||||||
Income taxes prepaid and receivable | 6,132 | 6,266 | ||||||
Prepaid expenses and other current assets | 18,675 | 14,520 | ||||||
Total current assets | 567,700 | 543,707 | ||||||
Property, plant and equipment, net | 459,388 | 454,302 | ||||||
Intangibles, net | 53,881 | 55,441 | ||||||
Goodwill | 168,311 | 166,796 | ||||||
Deferred income taxes | 70,174 | 68,648 | ||||||
Noncurrent receivables | 35,338 | 32,811 | ||||||
Other assets | 45,543 | 39,493 | ||||||
Total assets | $1,400,335 | $1,361,198 | ||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||
Notes and loans payable | $226 | $262 | ||||||
Accounts payable | 45,694 | 44,899 | ||||||
Accrued liabilities | 122,103 | 105,914 | ||||||
Current maturities of long-term debt | 1,821 | 1,799 | ||||||
Income taxes payable | 5,182 | 8,643 | ||||||
Total current liabilities | 175,026 | 161,517 | ||||||
Long-term debt | 518,656 | 514,120 | ||||||
Other noncurrent liabilities | 100,170 | 101,555 | ||||||
Deferred taxes and other liabilities | 11,339 | 10,991 | ||||||
Total liabilities | 805,191 | 788,183 | ||||||
SHAREHOLDERS' EQUITY | ||||||||
Preferred stock, par value $5.00 per share; | ||||||||
authorized 2,000,000 shares; none issued | - | - | ||||||
Class A Common Stock, par value $.001 per share; | ||||||||
authorized 100,000,000 shares; issued 37,447,669 in 2018 | ||||||||
and 37,395,753 in 2017 | 37 | 37 | ||||||
Class B Common Stock, par value $.001 per share; | ||||||||
authorized 25,000,000 shares; issued and | ||||||||
outstanding 3,233,998 in 2018 and 2017 | 3 | 3 | ||||||
Additional paid in capital | 428,859 | 428,423 | ||||||
Retained earnings | 533,759 | 534,082 | ||||||
Accumulated items of other comprehensive income: | ||||||||
Translation adjustments | (69,672 | ) | (87,318 | ) | ||||
Pension and postretirement liability adjustments | (50,549 | ) | (50,536 | ) | ||||
Derivative valuation adjustment | 6,433 | 1,953 | ||||||
Treasury stock (Class A), at cost 8,431,335 shares in 2018 | ||||||||
and 2017 | (256,876 | ) | (256,876 | ) | ||||
Total Company shareholders' equity | 591,994 | 569,768 | ||||||
Noncontrolling interest | 3,150 | 3,247 | ||||||
Total equity | 595,144 | 573,015 | ||||||
Total liabilities and shareholders' equity | $1,400,335 | $1,361,198 |
ALBANY INTERNATIONAL CORP. | |||||||||
CONSOLIDATED STATEMENTS OF CASH FLOW | |||||||||
(in thousands) | |||||||||
(unaudited) | |||||||||
Three Months ended | |||||||||
March 31, | |||||||||
2018 | 2017 | ||||||||
OPERATING ACTIVITIES | |||||||||
Net income | $10,482 | $10,974 | |||||||
Adjustments to reconcile net income to net cash used in operating activities: | |||||||||
Depreciation | 18,302 | 14,644 | |||||||
Amortization | 2,646 | 2,649 | |||||||
Change in other noncurrent liabilities | (377 | ) | (1,596 | ) | |||||
Change in deferred taxes and other liabilities | (784 | ) | (612 | ) | |||||
Provision for write-off of property, plant and equipment |
271 |
296 | |||||||
Non-cash interest expense | - | 211 | |||||||
Compensation and benefits paid or payable in Class A Common Stock |
289 |
989 | |||||||
Fair value adjustment on foreign currency option | 37 | 54 | |||||||
Changes in operating assets and liabilities that (used)/provided cash: | |||||||||
Accounts receivable | (31,467 | ) | (741 | ) | |||||
Contract assets | 2,116 | - | |||||||
Inventories | (9,244 | ) | (14,921 | ) | |||||
Prepaid expenses and other current assets | (4,063 | ) | (1,917 | ) | |||||
Income taxes prepaid and receivable | 102 | - | |||||||
Accounts payable | (2,538 | ) | 3,524 | ||||||
Accrued liabilities | (1,185 | ) | (10,971 | ) | |||||
Income taxes payable | (3,431 | ) | (2,486 | ) | |||||
Noncurrent receivables | 2,527 | (3,915 | ) | ||||||
Other, net | (2,630 | ) | (754 | ) | |||||
Net cash used in operating activities | (18,947 | ) | (4,572 | ) | |||||
INVESTING ACTIVITIES | |||||||||
Purchases of property, plant and equipment | (15,771 | ) | (25,045 | ) | |||||
Purchased software | (29 | ) | (38 | ) | |||||
Net cash used in investing activities | (15,800 | ) | (25,083 | ) | |||||
FINANCING ACTIVITIES | |||||||||
Proceeds from borrowings | 13,011 | 16,145 | |||||||
Principal payments on debt | (8,490 | ) | (20,602 | ) | |||||
Taxes paid in lieu of share issuance | (1,652 | ) | (1,364 | ) | |||||
Proceeds from options exercised | 147 | 75 | |||||||
Dividends paid | (5,474 | ) | (5,459 | ) | |||||
Net cash used in financing activities | (2,458 | ) | (11,205 | ) | |||||
Effect of exchange rate changes on cash and cash equivalents | 4,904 | 2,451 | |||||||
Decrease in cash and cash equivalents | (32,301 | ) | (38,409 | ) | |||||
Cash and cash equivalents at beginning of period | 183,727 | 181,742 | |||||||
Cash and cash equivalents at end of period | $151,426 | $143,333 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20180507006063/en/
Source:
Albany International Corp.
Investors
John Cozzolino,
518-445-2281
john.cozzolino@albint.com
or
Media
Heather
Kralik, 801-505-7001
heather.kralik@albint.com